Work

Abstract PS1-01-29: Real-world immune toxicity and survival outcomes by age in triple-negative breast cancer patients receiving pembrolizumab

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-01-29

Authors: G. Gorecki, O. Abioye, K. Babu, R. Srinishant, N. Gupta`, C. Hilton

Institution: Allegheny Health Network

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129767152

Cites:

Cited by:

Related to: